What's in Gruppo Oncologico del Nord-Ovest's pipeline?

Gruppo Oncologico del Nord-Ovest has 4 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Gruppo Oncologico del Nord-Ovest's portfolio?

Top competitors by shared drug class: Immatics US, Inc., Sanofi.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/gruppo-oncologico-del-nord-ovest.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Gruppo Oncologico del Nord-Ovest — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gruppo Oncologico del Nord-Ovest pipeline: 1 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Leucovorin and 5-FU	Leucovorin and 5-FU	marketed
docetaxel - cisplatin - 5-fluorouracil	docetaxel - cisplatin - 5-fluorouracil	phase 3	Taxane and platinum-based chemotherapy	Microtubules and DNA	Oncology
L-leucovorin	L-leucovorin	phase 3	Reduced folate cofactor / chemotherapy adjuvant	Thymidylate synthase (indirect; acts as cofactor)	Oncology

Therapeutic area mix

Oncology · 2
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Immatics US, Inc. · 1 shared drug class
Sanofi · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Gruppo Oncologico del Nord-Ovest:

Cite this brief

Drug Landscape (2026). Gruppo Oncologico del Nord-Ovest — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gruppo-oncologico-del-nord-ovest. Accessed 2026-05-17.